Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-14-000731
Filing Date
2014-11-12
Accepted
2014-11-12 15:06:17
Documents
1
Period of Report
2014-11-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 10799
  Complete submission text file 0000904454-14-000731.txt   12688
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1212
Type: 4 | Act: 34 | File No.: 001-36715 | Film No.: 141213531
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36715 | Film No.: 141213532

Mailing Address 4040 CAMPBELL AVENUE SUITE 210 MENLO PARK CA 94025
Business Address 4040 CAMPBELL AVENUE SUITE 210 MENLO PARK CA 94025 650-251-0005
NEVRO CORP (Issuer) CIK: 0001444380 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus